2025年1月23日 · BioMarin is a global biotechnology company that has developed medicines to treat conditions such as achondroplasia, severe hemophilia A, and several rare inherited and lysosomal storage diseases. Learn more.

BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health.

Healthcare professionals can learn more about our products and pipeline on our BioMarin Medical site. Visit Site

At BioMarin, we’re committed to delivering on the promise of genetic discoveries by translating them into transformative medicines. Our teams leverage their expertise in genomics and medicine to pursue breakthrough science aligned to five pillars.

Search BioMarin. Home; Products & Pipeline; Products. We provide eight important treatment options for people living with serious medical conditions. Learn more about our marketed products below. Note: The product information provided below is …

6 天之前 · We seek to make a big difference in genetic disorders. At BioMarin, through our unparalleled expertise in genetics and molecular biology, we will continue to develop targeted therapies that address the root cause of the conditions we seek to treat.

BioMarin proudly named to Forbes magazine's 2019 Best Midsize Employers list – a ranking of companies liked best by employees; The list has BioMarin ranked #4 in America and #1 in the 'Drug & Biotechnology Industry'

2023年10月20日 · BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders.

2025年1月7日 · Read the latest updates about BioMarin and learn more about our science, our people and the communities we support.

2024年9月5日 · Our pipeline includes investigational medicines across four areas of focus: central nervous system, cardiovascular, musculoskeletal/metabolic and non-oncology hematology. Learn more.